Vector particles for targeting CD34+ cells
AssigneeInstitut National De La Sante Et De La Recherche Medicale (Inserm)
InventorsFrançois-Loïc Cosset, Els Verhoeyen, Caroline Costa, Cecilia Frecha
Life of this patent
Estimating the term…
Abstract
The present invention relates to a vector particle for transferring biological material into cells, wherein said vector particle comprises at least: —a first protein which comprises the transmembrane and extracellular domains of the feline endogenous RD114 virus envelope glycoprotein, and —a second protein which comprises a ligand of the c-Kit receptor.
Claims17
A vector particle for transferring biological material into cells, wherein said vector particle comprises:
- a first protein which comprises the transmembrane and extracellular domains of the feline endogenous RD114 virus envelope glycoprotein, and
- a second protein which comprises a ligand of the c-Kit receptor;
- wherein the first protein is represented by SEQ ID NO:
- 2.
A vector particle for transferring biological material into cells, wherein said vector particle comprises:
- a first protein which comprises the transmembrane and extracellular domains of the feline endogenous RD114 virus envelope glycoprotein, and
- a second protein which comprises a ligand of the c-Kit receptor;
- wherein the second protein is represented by SEQ ID NO:
- 4.
An isolated protein represented by SEQ ID NO:
- 4.
Dependencies are inferred from the claim text.